Health & Biotech
Health & Biotech
Tim Boreham: Visioneering is flexing its muscles as it vies for a share of the $US2bn kids contact lens market
Health & Biotech
Health Kick Podcast: What’s holding back better breast cancer detection? And how is Volpara’s tech changing the game?
Health & Biotech
Tim Boreham: Can Phylogica finally make magic happen after nearly 15 years of trying?
Health & Biotech
Health Kick Podcast: Developing drugs, fighting fibrosis and squeezing squishometers
Health & Biotech
Dr Boreham’s Crucible: Uscom gets an A+ for everything but its share price
Health & Biotech
Health Kick Podcast: How Aussie health stocks are performing internationally and Prescient’s cancer-blocking innovation
Health & Biotech
Dr Boreham’s Crucible: Genetic Signatures lures the deep-pocketed backers in the battle of the bugs
Health & Biotech
Health Kick Podcast: The growth of musculoskeletal disorders, new markets created by ageing populations and OCC’s Avatar moment
Health & Biotech
Dr Boreham’s Crucible: PainChek on a painless path to success; shares up over 1000 per cent
Health & Biotech
Health Kick Podcast: The future of X-ray, a new way to image the body and challenging clinical practice
Health & Biotech